International journal of pharmaceuticsHumansPhotosensitizing AgentsPhotochemotherapyMolybdenumStaphylococcus aureus
Blue-light activated molybdenum cluster-based photosensitizers in NaDES - formulated creams for dermatological photodynamic therapy.
Michaela Kubáňová, Kaplan Kirakci, Leslie Boudesocque-Delaye, Laura Divoux, Antonín Kaňa, Jaroslav Zelenka, Tomáš Ruml, Emilie Munnier, Kamil Lang, Alexis Verger
Published: 202610.1016/j.ijpharm.2025.126491
Abstract
Photodynamic therapy (PDT) emerges as an innovative strategy combining light and drug treatment. The most prevalent use of this therapy is for the elimination of cancerous and pre-cancerous cells. However, in recent years PDT has been shown to be a s…
Preview only. Read the full abstract at the source